pOTB7-MEIS2-2
pOTB7-MEIS2-2 (Catalog No. PVT25959) is a HUMAN MEIS2 cDNA GENE TEMPLATE / clone carried in E. coli, not a bacterial protein-expression plasmid. The datasheet states Vector type: Gene template, Fragment type: cDNA, species: Human, Host: Escherichia coli, Replicon: pUC, Growth Strain: DH5a, 37C culture, Chloramphenicol (Chl) resistance, alias NM_002399.3; CPCMR; HsT18361; MRG1, and M13F / M13R sequencing primers. MEIS2 encodes Homeobox protein Meis2; the reviewed human entry is NCBI Gene ID 4212 / UniProt O14770, 477 amino acids (about 51,790 Da). IMPORTANT SEQUENCE LIMITATION: six-frame translation of the supplied 3172 bp insert matches 341 of the 477 MEIS2 residues (approximately 71 percent) in the reverse-complement -1 frame, and the sequence contains a long poly(T) tract representing a reverse-oriented poly(A) tail, so the insert is a partial, reverse-oriented cDNA / 3-prime fragment rather than a complete coding sequence. No expression promoter is documented and no recombinant protein production is claimed. Supplied as lyophilized DNA for research use.
Ordering Information
| Catalog No. |
Product Name |
Size |
Form |
Availability |
| PVT25959 |
pOTB7-MEIS2-2 |
3172 bp |
Lyophilized powder |
In Stock |
Technical Specifications & Vector Traits
| Alias | NM_002399.3;CPCMR; HsT18361; MRG1 | Replicon | pUC |
| Growth strain | DH5a | Culture conditions | 37Centigrade |
| Host | Escherichia coli | Vector type | Gene template |
| Fragment type | cDNA | Species | Human |
| Prokaryotic resistance | Chloramphenicol | | |
| Target / Gene ID | 4212 | UniProt | O14770 (human MEIS2, 477 aa) |
Handling Guidelines & Cautions:
- This product is FOR RESEARCH USE ONLY!
▶ Click to expand/collapse pOTB7-MEIS2-2 Sequence (3172 bp)
GGCTCTTCTCTTTCTCGCACCCGACATAGATGCCTCGAGTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTCAAAAATGAAATATTTATTACCGCTTTTTGTGACTTAACACCTTTTTTTTTTAACATAACGTCACAGTCCTCATACAAGTATTTTAATGTAAATTTGACAAAGCTTAAAGGTAACAGCATTTTCTTCTAGTGAGGAACACGTGCTGAGAAAAGAAGAATTCATGGACATACAATACCAATTCCACAGCAGATCTGATACTAGCAAAAACATTCTTTTTTTTTTCAATTGAGGTAAACACATAGAATATCTAACATGAAACAATTAATAGACCGAACTCTGTACGAAGTTTGTTACAGTATTCTCTTGCTCCTTTTTATCCCCCAAGCTTTGAGTTTCTGATAAAGTCCTAGTTATGGTTCAATGACCATTAATAACTTTTTTTGTGTTGAGGAAAGCTGCCCAACTTAAGATTGTTTTGTCCACAACCAAGGCTCAGAACTCCTGGAAGAAGCTCCTGCTCTGTCTTTAAATCTTCATTGGCAAGCTCTTTGAAGAAGAGTCCCCCAAAAATAATAATAAGAATTGGCTTATGAAGCACGAACTATAAAGATCTGTTTGAAACTAAAGGACACATTTATGGAGGAACAAAGGCCGGGCATGAAAACACATTCTTGAAGCTGGAGTTCGAGTGATGAGGTTCAGCCAAAAGTTCATCATGATCTCCAGTGTGGTTCTTTTCTCATTGGCCCAACAGGTTTAAAATATATACCACAGTCTCTCCTGGATGGTGAATTCACTGATGAACCAAAACAGTCATTCTTTTGGGAACAACACACATAGTGTGGAAAACAAGGATATATTTTTTTTTCTCTTCTAAAACTATTTGAGGCAACATAACGGCGTGATCAACAGAAATGTACAAGTTTAACTTAGTTCCTATATTTATACTACAGTAGTTATAACTCTCGGAGTCTTTTTCCAGAGGATCTTTACATGGACAGAATTGTCTCAGTCAGCCCATGATTTCACATTTGTGTTCTTGTTGCATTGGTCCTCTGTTGCTTGATGAAAAATGACAAAAGTAAAAAATAATCACAGCTGTCTGGAATTTCATATTAAGTGTCAACATCTGGTCAAAGTTCAGAAAGTCTTAAAATAGTTTTTGCGTGTGTTTCCTTTTCCCTTGAGTTCCCTTATACTATTGGGCATGAATGTCCATAACCTGTCCGCCAACATTGGGATCTACAGAATTTAACATTGTGGGGCTCTGTGCTGACATAGTCATTCCAGGGTGGGTAGGGGGTCCTCCGTGCATCATCATGGCTGGGTGGTGGGGATGGCTTGGCAAATATGAATGCATTGGGGGTCCATGTCTTAATTGAGTAGGGTGTGGGGTCATCTGGGGAGGAGTGTAACTTGGCTGTGCCATACTCATTCCCATAGGACCACCCTGAGAAACGTAGTCCCCTGGCATGCTCTGCAAACTTCCCCCTTGCTTTGCGATTGCTTTACATGATGAAGGTTACATGTAGTGCCATTGCCCATCCATGCCCATATTCATGCCCATTCCACTCATAGGTCCTGCAGGCCGGATCCCCATGTGTTGCTGACCATCCAACACAAAGCTCCCCATGGGCTGACCCTCTGGACTATATGCTGCTCCTTGGCTCACTGCTCGATTTGACTGGTCAATCATGGGCTGTACTATTCTTCTTCTGGCATTAATAAACCAGTTGTTTACTTGGAGAATTGTAAGTCCTGTGTCTTGCGCTAACTGTTTCTTCTGCTCTTCGGAAGGGTACGGATGTGTGAGATGCTGGAAGAGCCATGCTCTCATGATATTTGTTGCTACTTTGGGGAAAATGCCTCTTTTCTTCTGGCGTTTTTTGTCCTTATCCGGATCATCATCGTCACCTGTACCAGGTGAAGCTACACTGTTGTCTAAACCATCCCCTTGCTCACTGCTGTTGTCTCCGCTCTGGGAAGCATGGCCCCCACTGGAGGGCCCTGGGGTGCCTGCTGAGTGGGTTGAGGTTGCATCATCGTGGTCTCGCCAAGAAGAAGGGTTATGGTCAGCGAGATTTGTGGAGGAGCCTGAAAGTTCTTCATGATCTGACTTGGAGCTGCCGTCTCTTTCATCAATGACGAGGTCGATGGGCATTTTCCCCTTCAAACAGCTAATGTATCGGTGGCAGAAGTTATCGCACAGTTCGTGGACCTTTTCTAACTCCAAAAGATGAAACCTTAGTACTTGTATTGCTTGTATCATCAAATTGTCCAGCTCTGGATTTGAGGAAAAAAGTGGCTTTTCGGCGCGAACCTGCTTGGCGAAGACCGCGATGTCCTCGTTGAAGGAGTCGGAGGAGCAGACGTCTCCGCCAGCCACTCCAGGTTCCCGGGGAGTGCAGGTCGCCAGCTCGCACTTCTCAAAGACCAGAGCTAACAGAGGAAACAACGGGTGCCCATAGATCGCGTCCTTGTCCCGCTTCAAGGCGTCGTTGACAGCGGATCCCATACTGGCCGGCATGACATTGGGGTGCGGGGCGTGCGCGCCGTAGTGCTGTGTGGCGTGGAGCGGCGGCCCGTGGTTCAGGTGGTGAACCGGGGGGATCGGCCGCGGCGCGTGAGGGTCTCCGTACATGGAAGCGGGAACCCCTACTCCGTCCATCCCGCCGTAATGGGGCAGCTCATCGTATTCTAGTTCATTTTCCCATCACTCCCGGCTCCTGCCTAACTGGGTCTTGCCGGGGACGTTTGGCATGGCGCTCTAGCTTTTGTTCCTTTTAATTCCGCGGCCTCCCTCTCCTCTGCCCGCCGATTACAGCACCCCGAAGGCTTCCTGCTAACGTCCAAGGGCAGCAAGCTCTGCAGACGGTACCACTGCCGGGCTAAATTTTTTATTAAGTGGCACTTTCTTTTCTACGCAGATCCAGCAACCTTGTCAATACTCATTTTTTTCCAGGACCAGAAGAGACCAGCTTAACTCAGAGCACACTCCCTCCAAGCGGTGCGGACAAGGGGCCACCCCGAGAGTCTTTGGGGGCCGCGGCGGAATCGGGAGGGAGGAAGTGAGGAGGCAGTCATCTGGGTCCGAGTAGCCAAGGGCCCTCGTGCCGAATCGCCACCCAA
References
- Strausberg RL, Feingold EA, Grouse LH, et al. (2002). Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proceedings of the National Academy of Sciences U S A, 99(26), 16899-16903. PMID: 12477932
- Yanisch-Perron C, Vieira J, Messing J. (1985). Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene, 33(1), 103-119. PMID: 2985470
- Sanger F, Nicklen S, Coulson AR. (1977). DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences U S A, 74(12), 5463-5467. PMID: 271968
FAQ
Q: What is pOTB7-MEIS2-2?A: A human MEIS2 cDNA clone / gene template propagated in E. coli. The datasheet explicitly says Vector type: Gene template and Fragment type: cDNA. It is a sequence resource for PCR, sequencing and subcloning, not an expression construct.
Q: Which gene and identifiers apply?A: Human MEIS2, alias NM_002399.3; CPCMR; HsT18361; MRG1 in this datasheet. The reviewed human entry is NCBI Gene 4212 / UniProt O14770, Homeobox protein Meis2, 477 amino acids and about 51,790 Da.
Q: Is the full MEIS2 coding sequence present?A: No. six-frame translation of the supplied 3172 bp insert matches 341 of the 477 MEIS2 residues (approximately 71 percent) in the reverse-complement -1 frame, and the sequence contains a long poly(T) tract representing a reverse-oriented poly(A) tail, so it is a partial, reverse-oriented cDNA / 3-prime fragment rather than a complete coding sequence. Verify the covered interval and orientation before designing expression constructs or PCR assays.
Q: Can this plasmid be used to express MEIS2 protein?A: Not as documented. The datasheet names no expression promoter, induction condition, ribosome-binding site or tag, and the insert is incomplete. Subclone the required coding region into a dedicated expression vector if protein production is needed.
Q: Which resistance, origin and host are used?A: Chloramphenicol (Chl) resistance selects the plasmid, a pUC replicon supports high-copy propagation in E. coli, DH5a is the listed growth strain and culture is at 37C. No ampicillin or kanamycin marker is stated for this catalogue.
Q: Which sequencing primers are recommended?A: M13F (TGTAAAACGACGGCCAGT) and M13R (CAGGAAACAGCTATGACC), which flank the cloned cDNA in pUC-type vectors. Use them to confirm the insert boundaries and orientation before downstream work.
Q: How is the DNA supplied and handled?A: As 3172 bp lyophilized plasmid DNA for research use. Centrifuge briefly, resuspend in nuclease-free water and store at 2-8C. Propagate in E. coli DH5a with chloramphenicol selection and re-verify by sequencing.
Q: What is the main application?A: A sequence-verified human MEIS2 cDNA fragment for PCR amplification, Sanger sequencing, probe generation and subcloning into expression or reporter backbones. It is not a protein-production reagent. For research use only.